Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)
Tramadol Hydrochloride
Product Images NDC 45865-969
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
This is a chart showing the concentration of Tramadol (measured in ng/mL) at different time intervals (measured in hours) for two different medications: Tramadol Hydrochloride Extended-Release Tablets, with a dosage of 200 mg once daily, and Tramadol Hydrochloride Tablets with a dosage of 50 mg every 6 hours.*
Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a graph depicting the concentration of M1 (in ng/mL) over time (in hours) for two different medications: Tramadol Hydrochloride Extended-Release Tablets (200 mg once daily) and Tramadol Hydrochloride Tablets (50 mg every 6 hours). The chart shows the concentration values of M1 ranging from 0 to 120 ng/mL, and the time values ranging from 0 to slightly above 24 hours.*
Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This appears to be a graph displaying the percent of patients who have achieved various levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets in Study 023 WOMAC Pain Responder Analysis. Different doses (100mg, 200mg, 300mg, 400mg) of the medication are included and compared to a placebo. The X-axis measures response threshold in percent improvement from baseline while the Y-axis shows the percent of patients achieving that level of response.*
Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This is a table displaying the response levels of patients with arthritis pain who were given Tramadol Hydrochloride Extended-Release Tablets (versus a placebo) in Study 015. The percentage of patients achieving various response thresholds are indicated on the left vertical axis, while the Response Threshold (expressed as a percent improvement from baseline) is indicated on the horizontal axis.*
Pdp (969)
This is a label description for Tramadol HCL ER tablets of 100mg strength with a controlled substance classification of CIV. There is no additional information available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
